GUSTAVO VELA: Open Payments
NPI 1013109370 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$801 in 24 payments from 14 companies in 2025. Trend: 2023 $185 · 2024 $1,064 · 2025 $801
Food & beverage: $587Education: $214
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 3 | $135 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| SEAGEN INC. | 1 | $100 |
| Astellas Pharma US Inc | 1 | $99 |
| Celgene Corporation | 3 | $74 |
| PFIZER INC. | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| GM Pharmaceuticals, Inc. | 1 | $42 |
| Eisai Inc. | 2 | $39 |
| Aveo Pharmaceuticals, Inc. | 2 | $36 |
Products named: ADSTILADRIN, ENHERTU, REBLOZYL, Vanacof, Lenvima, FOTIVDA, Nubeqa, PLUVICTO.
Industry payments across TX — which companies pay providers there.
